GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individualâs nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
äŒæ¥ã³ãŒãWGS
äŒç€ŸåGeneDx Holdings Corp
äžå Žæ¥Sep 04, 2020
æé«çµå¶è²¬ä»»è
ãCEOãStueland (Katherine A)
åŸæ¥å¡æ°1000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Sep 04
æ¬ç€Ÿæåšå°333 Ludlow Street
éœåžSTAMFORD
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·06902
é»è©±çªå·18887291206
ãŠã§ããµã€ãhttps://sema4.com/
äŒæ¥ã³ãŒãWGS
äžå Žæ¥Sep 04, 2020
æé«çµå¶è²¬ä»»è
ãCEOãStueland (Katherine A)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã